SOLV logo

SOLV
Solventum Corp

597
Mkt Cap
$14.36B
Volume
791,989.00
52W High
$88.20
52W Low
$60.70
PE Ratio
9.55
SOLV Fundamentals
Price
$82.98
Prev Close
$82.79
Open
$83.11
50D MA
$75.76
Beta
0.74
Avg. Volume
1.26M
EPS (Annual)
$2.76
P/B
2.89
Rev/Employee
$375,181.82
Loading...
Loading...
News
all
press releases
Invesco Ltd. Sells 36,589 Shares of Solventum Corporation $SOLV
Invesco Ltd. lessened its position in Solventum Corporation (NYSE:SOLV - Free Report) by 1.4% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing
BDX teams up with ChemoGLO to expand hazardous drug testing, aiming to boost safety in healthcare environments.
Zacks·8d ago
News Placeholder
HIMS Stock Jumps After Buyout Deal, Boosts Blood Collection Efficiency
Hims & Hers is set to acquire YourBio Health, adding bladeless microneedle tech to transform the blood collection experience.
Zacks·9d ago
News Placeholder
Solventum (NYSE:SOLV) Downgraded to "Hold" Rating by Zacks Research
Zacks Research downgraded Solventum from a "strong-buy" rating to a "hold" rating in a report on Monday...
MarketBeat·9d ago
News Placeholder
Solventum Corporation (NYSE:SOLV) Given Consensus Recommendation of "Hold" by Brokerages
Shares of Solventum Corporation (NYSE:SOLV - Get Free Report) have been given a consensus recommendation of "Hold" by the twelve research firms that are presently covering the firm, Marketbeat.com...
MarketBeat·12d ago
News Placeholder
Solventum Corporation $SOLV Shares Purchased by Laurel Wealth Advisors LLC
Laurel Wealth Advisors LLC raised its stake in Solventum Corporation (NYSE:SOLV - Free Report) by 6,623.3% during the second quarter, according to its most recent disclosure with the SEC. The fund...
MarketBeat·14d ago
News Placeholder
Solventum Corporation $SOLV Stock Position Raised by Boston Partners
Boston Partners increased its holdings in shares of Solventum Corporation (NYSE:SOLV - Free Report) by 9.2% during the 2nd quarter, according to the company in its most recent disclosure with the...
MarketBeat·15d ago
News Placeholder
Solventum (NYSE:SOLV) Reaches New 12-Month High - Still a Buy?
Solventum (NYSE:SOLV) Hits New 12-Month High - Here's Why...
MarketBeat·16d ago
News Placeholder
Solventum Reaches Analyst Target Price
In recent trading, shares of Solventum Corp (Symbol: SOLV) have crossed above the average analyst 12-month target price of $84.70, changing hands for $85.77/share. When a stock reaches the target an...
Nasdaq News: Markets·17d ago
News Placeholder
Solventum Corporation $SOLV Shares Sold by Prudential PLC
Prudential PLC lessened its stake in Solventum Corporation (NYSE:SOLV - Free Report) by 55.8% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 6,968 shares of the...
MarketBeat·17d ago

Latest SOLV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.